Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,798 | 3,257 | 5,245 | 6,970 | 8,150 |
| TOTAL | $4,971 | $3,516 | $5,318 | $7,143 | $8,445 |
| Non-Current Assets | |||||
| PPE Net | 7,513 | 7,603 | 7,746 | 7,928 | 8,107 |
| Intangibles | 325 | 327 | 329 | 332 | 334 |
| Other Non-Current Assets | 15 | 19 | 9 | 14 | 14 |
| TOTAL | $7,852 | $7,949 | $8,084 | $8,274 | $8,455 |
| Total Assets | $12,823 | $11,465 | $13,402 | $15,417 | $16,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,096 | 555 | 771 | 609 | 391 |
| Accrued Expenses | 263 | 259 | 180 | 340 | 144 |
| TOTAL | $1,359 | $813 | $951 | $948 | $534 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,500 | 1,500 |
| TOTAL | $N/A | $N/A | $N/A | $1,500 | $1,500 |
| Total Liabilities | $1,359 | $813 | $951 | $2,448 | $2,034 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,677 | 11,814 | 11,779 | 11,746 | 11,746 |
| Retained earnings | -139,375 | -137,019 | -135,164 | -133,050 | -131,081 |
| TOTAL | $11,464 | $10,652 | $12,451 | $12,969 | $14,866 |
| Total Liabilities And Equity | $12,823 | $11,465 | $13,402 | $15,417 | $16,900 |